Transition Bio
Pre-clinicalSolving the Unsolvable Redefining drug discovery at the molecular level By combining the technology and data engine of Harvard’s Weitz Lab and the University of Cambridge’s Knowles Lab, we created the only end-to-end condensate drug discovery platform built on molecular insights. More About Us ⟶
Founded
2020
Focus
ProteomicsAI / Machine Learning
About
Solving the Unsolvable Redefining drug discovery at the molecular level By combining the technology and data engine of Harvard’s Weitz Lab and the University of Cambridge’s Knowles Lab, we created the only end-to-end condensate drug discovery platform built on molecular insights. More About Us ⟶
Funding History
2Total raised: $45M
Series A$40MNorthpond VenturesMar 15, 2022
Seed$5MUndisclosedJan 15, 2020
Company Info
TypePrivate
Founded2020
LocationCambridge, United Kingdom
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
Abbexa
Pre-clinical · Cambridge
Accentus Medical
Pre-clinical · Oxford
AbOliGo
Pre-clinical · London
Bigespas
Pre-clinical · London
Actimed Therapeutics
Pre-clinical · London
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile